
CaSSS Bioassay
futureEngineered viral and non-viral vectors can be designed as directly administered products or as critical reagents in the manufacture of gene modified cell therapies. These vectors require some form of potency testing prior to use in pre-clinical…

CHI’s Immunogenicity & Bioassay Summit
futureMy workshop "Biostatistics for Beginners" will be offered again this year at CHI's Immunogenicity & Bioassay Summit. I plan to expand the scope and bring on a co-instructor(s) to cover immunogenicity in addition to bioassay. Details on…

Environmental Science and Communication Studies Dyad course
futureNancy Sajjadi is an invited speaker for the Environmental Science and Communication Studies Dyad course, Renaissance Scholars Honors Program, at Montgomery Community College in Germantown MD. This community service engagement is a private e…

International Society for BioProcess Technology (ISBiotech )12th Spring Meeting
futureNancy Sajjadi will be a speaker at the ISBiotech session, "Using an Equivalence Approach to Establish Lot Release Limits for Vector Dose During Pre-Clinical Studies and Early Phase Clinical Trials."